- Home
- GH vs SYM Comparison
GH vs SYM Comparison
Compare GH & SYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- SYM
- Stock Information
- Founded
- GH 2011
- SYM 2005
- Country
- GH United States
- SYM United States
- Employees
- GH N/A
- SYM N/A
- Industry
- GH Medical Specialities
- SYM Industrial Machinery/Components
- Sector
- GH Health Care
- SYM Industrials
- Exchange
- GH Nasdaq
- SYM Nasdaq
- Market Cap
- GH 4.9B
- SYM 5.4B
- IPO Year
- GH 2018
- SYM N/A
- Fundamental
- Price
- GH $65.46
- SYM $68.57
- Analyst Decision
- GH Strong Buy
- SYM Hold
- Analyst Count
- GH 22
- SYM 14
- Target Price
- GH $64.91
- SYM $40.75
- AVG Volume (30 Days)
- GH 2.2M
- SYM 2.2M
- Earning Date
- GH 10-29-2025
- SYM 11-17-2025
- Dividend Yield
- GH N/A
- SYM N/A
- EPS Growth
- GH N/A
- SYM N/A
- EPS
- GH N/A
- SYM N/A
- Revenue
- GH $828,849,000.00
- SYM $2,193,031,000.00
- Revenue This Year
- GH $28.30
- SYM $25.99
- Revenue Next Year
- GH $22.98
- SYM $20.37
- P/E Ratio
- GH N/A
- SYM N/A
- Revenue Growth
- GH 28.74
- SYM 35.75
- 52 Week Low
- GH $20.14
- SYM $16.32
- 52 Week High
- GH $68.23
- SYM $79.58
- Technical
- Relative Strength Index (RSI)
- GH 59.00
- SYM 59.56
- Support Level
- GH $61.00
- SYM $63.65
- Resistance Level
- GH $68.22
- SYM $79.58
- Average True Range (ATR)
- GH 2.50
- SYM 5.82
- MACD
- GH 0.12
- SYM 0.55
- Stochastic Oscillator
- GH 64.47
- SYM 59.56
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About SYM Symbotic Inc.
Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys end-to-end technology solutions that dramatically improve supply chain operations. Th company also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.